Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Jean Luc Harousseau, Meletios A. Dimopoulos, Michael Wang, Alessandro Corso, Christine Chen, Michel Attal, Andrew Spencer, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert D. Knight, Donna M. Weber

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences